Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-08 08:27 am Purchase | 2021-08-02 | 13G | Icosavax, Inc. ICVX | SANOFI | 3,155,169 8.080% | 3,155,169 (New Position) | Filing History |
| 2022-02-03 4:29 pm Sale | 2021-12-31 | 13G | Sanofi SNY | BlackRock Inc. BLK | 93,084,420 7.400% | -767,112 (-0.82%) | Filing |
| 2021-08-12 4:00 pm Sale | 2021-08-02 | 13D | Telesis Bio, Inc. TBIO | SANOFI | 204,691 4.900% | -66,667 (-24.57%) | Filing History |
| 2021-03-31 11:19 am Purchase | 2021-03-25 | 13G | LAVA Therapeutics N.V. LVTX | SANOFI | 1,919,455 7.000% | 1,919,455 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Sanofi SNY | AMUNDI | 63,318,143 5.000% | 63,318,143 (New Position) | Filing |
| 2021-02-11 10:46 am Purchase | 2020-02-13 | 13G | Fulcrum Therapeutics, Inc. FULC | SANOFI | 3,363,050 4.600% | 3,363,050 (New Position) | Filing History |
| 2021-02-04 06:57 am Purchase | 2020-07-20 | 13G | Telesis Bio, Inc. TBIO | SANOFI | 271,357 6.600% | 271,357 (New Position) | Filing History |
| 2021-02-01 08:17 am Purchase | 2020-12-31 | 13G | Sanofi SNY | BlackRock Inc. BLK | 93,851,532 7.500% | 11,949,247 (+14.59%) | Filing |